Einloggen
Einloggen
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrieren
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

AMGEN INC.

(AMGN)
  Bericht
Verzögert Nasdaq  -  22:00 03.10.2022
230.44 USD   +2.24%
22.09.US-Aktien beenden Donnerstag trotz Gewinnen im Gesundheitswesen niedriger
MT
22.09.US-Aktien enden am Donnerstag trotz eines Anstiegs bei Aktien aus dem Gesundheitswesen niedriger
MT
19.09.Novartis' Biosimilar für Osteoporose-Medikament Xgeva entspricht in Sicherheit und Wirksamkeit der Referenztherapie
MT
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivateFonds 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-NewsMarketScreener Analysen
Nachrichten in anderen Sprachen über AMGEN INC.
27.09.AstraZeneca Says Bronchial Asthma Treatment Approved in Japan
22.09.US Stocks End Lower Thursday Despite Healthcare Gains
22.09.US Stocks End Lower Thursday Despite Surge in Healthcare Shares
21.09.EU approves AstraZeneca-Amgen treatment for severe asthma
19.09.Novartis' Biosimilar for Osteoporosis Drug Xgeva Matches Reference Therapy in Safety, E..
16.09.Amgen : Is Ready to Meet Growing Demand for Innovative Medicines, Says Bradway in Bloomber..
16.09.USA-Les valeurs à suivre à Wall Street (actualisé)
16.09.Consumer group says drugmakers abuse U.S. patent system to keep prices high
15.09.Transcript : Amgen Inc. Presents at BofA Securities Global Healthcare Confere..
13.09.Asthma Peak Week : What You Need to Know About Indoor Air Pollution
13.09.Transcript : Amgen Inc. Presents at Morgan Stanley 20th Annual Global Healthc..
12.09.Health Care Up on Cyclical Bias -- Health Care Roundup
12.09.Wall Street posts fourth straight day of gains ahead of CPI report
12.09.Amgen announces webcast of 2022 bank of america merrill lynch global healthcare confere..
12.09.Wall Street closes higher ahead of CPI report
12.09.Wall Street looks to extend its winning streak ahead of CPI report
12.09.Bristol-Myers Stock Gains While Amgen Falls on US FDA Approval of Psoriasis Treatment S..
12.09.Transcript : Amgen Inc. Presents at European Society for Medical Oncology Ann..
12.09.Wall Street hits more than two-week high on energy, tech gains
12.09.Borsa Usa ai massimi di due settimane grazie a tech, energia
12.09.Wall Street hits more than two-week high on energy, tech gains
12.09.Sector Update: Health Care Stocks Climb Premarket Monday
12.09.MarketScreener's World Press Review : September 12, ..
12.09.Amazon réinitialise, UPS embauche, Deere mise sur l..
12.09.Lumakras® (sotorasib) combined with vectibix® (panitumumab) shows confirmed 30% objecti..
12.09.Amgen Announces Lumakras Combined with Vectibix (Panitumumab) Shows Confirmed 30% Objec..
12.09.Amgen Says Lumakras Has 'Superior' Progression-Free Survival Rate Over Docetaxel in Pat..
12.09.Amgen says Lumakras cuts risk of lung cancer progression by 34%
12.09.Amgen Announces Detailed Results from the Global Phase 3 CodeBreak 200 Trial
09.09.Amgen announces positive new data at eadv 2022 for otezla
09.09.UCB presenteert studiegegeven romosozumab
08.09.Amgen announces webcast of 2022 morgan stanley global healthcare conference
08.09.Transcript : Amgen Inc. Presents at 2022 Wells Fargo Healthcare Conference, S..
08.09.Amgen announces positive new data at eadv 2022 for otezla® (apremilast)
08.09.Amgen Announces Positive New Data At EADV 2022 for Otezla®
07.09.Amgen to webcast investor call at esmo 2022
07.09.Transcript : Amgen Inc. Presents at Citi's 17th Annual BioPharma Conference, ..
02.09.Amgen announces webcast of 2022 wells fargo healthcare conference
02.09.Amgen announces webcast of 2022 citi global healthcare conference
31.08.Amgen announces topline data from lumakras phase 3 trial in non-small cell lung cancer
30.08.Amgen Phase 3 Lumakras Study Achieves Progression-Free Survival Primary Endpoint
30.08.Amgen Announces Topline Data from LUMAKRAS® Phase 3 Trial in Non-Small Cell Lung Cancer
30.08.Amgen to present new, positive clinical and real-world data across inflammation portfol..
29.08.Amgen Presents New Compelling Data from the Phase 3 FOURIER Open Label Extension Studie..
25.08.Amgen : How Genetic Validation Helped Innovate Medicine for Patients with High Cholesterol
25.08.Molecular Partners fait un énorme bénéfice grâce à un apport de Novartis
23.08.Nasdaq ticks up on hopes of less aggressive rate hikes after weak PMI data
23.08.Amgen Reports Positive Results From Phase 3 Study of Soliris Biosimilar Candidate ABP ..
23.08.Amgen Reports Top-Line Results From Phase 3 Study of ABP 959, Biosimilar Candidate for ..
23.08.Amgen announces positive top-line results from phase 3 study of abp 959, biosimilar can..
23.08.Amgen Inc. Announces Positive Top-Line Results from Phase 3 Study of ABP 959, Biosimila..
23.08.Amgen Reports Positive Results From Blood-Disease-Treatment Study
22.08.Insider Sell: Amgen
22.08.Amgen to present new data at esc congress 2022 highlighting up to 8.5 years of repatha®..
18.08.Amgen Inc : Entry into a Material Definitive Agreement, Financial Statements and Exhibits ..
16.08.Amgen : Statement on Drug Pricing Provisions Included in “Inflation Reduction Act&rd..
16.08.Amgen Chronicles : Fresh Water and Fresher Ideas About Sustainability in Puerto Rico
13.08.Amgen : Statement on Drug Pricing Provisions Included in “Inflation Reduction Act&rd..
12.08.Biotech stocks pin bounce back hopes on M&A boost
11.08.Senate Finance Committee looks at Amgen taxes, widening drugmaker probe
11.08.Senate finance committee chairman wyden sends amgen letter inqui…
09.08.Amgen : Statement on Drug Pricing Provisions Included in “Inflation Reduction Act&rd..
08.08.Amgen Presents New Tarlatamab Clinical Data At WCLC 2022
08.08.Transcript : Amgen Inc. - Special Call
08.08.Transcript : Amgen Inc. Presents at International Association for the Study o..
08.08.EFFECTOR Therapeutics Names Douglas Warner Chief Medical Officer
07.08.Amgen says Lumakras plus immunotherapy for lung cancer needs further study
05.08.Pfizer in advanced talks to buy Global Blood Therapeutics for $5 bln - WSJ
05.08.Another case of good news is bad news
05.08.Amgen reports second quarter 2022 financial results
05.08.USA-Les valeurs à suivre à Wall Street (actualisé)
05.08.Amgen Signals Additional $100 Million Hit to Revenue From Foreign Exchange Following Vo..
05.08.MarketScreener’s World Press Review : August 5, 2022
05.08.AMGEN INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF ..
05.08.Coinbase & BlackRock unis, Amgen prend Chemocentryx..
05.08.Bolsa de Madrid: ¿Agosto siguiendo los pasos de julio?
05.08.Août sur la lancée de Juillet ?
05.08.EN DIRECT DES MARCHES : Stellantis, Sanofi, Ipsen, EDF, Allianz, L..
04.08.Amgen : REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS - Form 8-K
04.08.Healthcare Shares Slip Amid Deal News -- Healthcare Roundup
04.08.Transcript : Amgen Inc., Q2 2022 Earnings Call, Aug 04, 2022
04.08.Amgen 2Q Profit Jumped After Write-Off From 2021 Acquisition
04.08.Tranche Update on Amgen Inc.'s Equity Buyback Plan announced on April 21, 2011.
04.08.Amgen Inc. Provides Earnings Guidance for the Full Year 2022
04.08.Amgen : Q2 Earnings Snapshot
04.08.Amgen's Q2 Earnings, Revenue Rise; Adjusts 2022 Revenue Guidance
04.08.Earnings Flash (AMGN) AMGEN Reports Q2 EPS $4.65
04.08.Earnings Flash (AMGN) AMGEN Posts Q2 Revenue $6.59B
04.08.Amgen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30..
04.08.Sector Update: Health Care Stocks Slipping Ahead of Thursday Close
04.08.Sector Update: Health Care
04.08.Amgen to Acquire Drugmaker ChemoCentryx in $3.7 Billion Deal
04.08.Earnings Reaction History: Amgen Inc, 55.6% Follow-Through Ind..
04.08.Top Midday Gainers
04.08.Global markets live: Bayer, Merck, eBay, MetLife, Eli Lilly...
04.08.Still seeing the glass half full
04.08.Amgen : accord pour fera l'acquisition de ChemoCentryx
04.08.ChemoCentryx Shares Soar Premarket on Amgen Takeover Deal
04.08.Amgen to Acquire ChemoCentryx in $3.7 Billion Deal
04.08.Amgen : TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH - Form 8-K